%D8%A2%D9%8A%D8%B2%D9%88%D8%AA%D8%B1%D9%8A%D8%AA%D9%8A%D9%86%D9%88%D9%8A%D9%86%D8%A7%DB%8C%D8%B2%D9%88%D8%AA%D8%B1%D8%AA%DB%8C%D9%86%D9%88%DB%8C%D9%86Category:IsotretinoinIsotretinoinIsotretinoinIsotretinoinIsotretino%C3%ADnaIsotretinoiin%D8%A7%DB%8C%D8%B2%D9%88%D8%AA%D8%B1%D8%AA%DB%8C%D9%86%D9%88%DB%8C%D9%86IsotretinoiiniIsotr%C3%A9tino%C3%AFne%D7%90%D7%99%D7%96%D7%95%D7%98%D7%A8%D7%98%D7%99%D7%A0%D7%95%D7%90%D7%99%D7%9FIsotretinoina%E3%82%A4%E3%82%BD%E3%83%88%E3%83%AC%E3%83%81%E3%83%8E%E3%82%A4%E3%83%B3%EC%9D%B4%EC%86%8C%ED%8A%B8%EB%A0%88%ED%8B%B0%EB%85%B8%EC%9D%B8Isotretino%C3%AFneIzotretynoinaIsotretino%C3%ADna%D0%98%D0%B7%D0%BE%D1%82%D1%80%D0%B5%D1%82%D0%B8%D0%BD%D0%BE%D0%B8%D0%BDIzotretinoinIzotretinoinIzotretinoinIsotretinoin%E0%B0%90%E0%B0%B8%E0%B1%8B%E0%B0%9F%E0%B1%8D%E0%B0%B0%E0%B0%BF%E0%B0%9F%E0%B0%BF%E0%B0%A8%E0%B1%8B%E0%B0%AF%E0%B0%BF%E0%B0%A8%E0%B1%8D%E0%B9%84%E0%B8%AD%E0%B9%82%E0%B8%8B%E0%B9%80%E0%B8%97%E0%B8%A3%E0%B8%95%E0%B8%B4%E0%B9%82%E0%B8%99%E0%B8%AD%E0%B8%B4%E0%B8%99%C4%B0zotretinoinIsotretinoinQ287029%E7%95%B0%E7%B6%ADA%E9%85%B8
about
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid TumorsEffects of Roaccutane on Ca, P, PTH and Vitamin D Metabolites in the Treatment of Sever AcneErlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant GliomaEffect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell RecoveryVorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous SystemThe Use of Teledermatology in the Treatment of Patients With Severe Acne on IsotretinoinTemozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma MultiformeBiological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous TreatmentIsotretinoin Plus Interferon in Treating Patients With Recurrent CancerBiological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney CancerCombination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous LeukemiaEarly Non-Ablative Fractional Laser Resurfacing for Acne Scars After Treatment With Oral IsotretinoinOpen Label Study of Isotretinoin in Mild to Moderate Alzheimer's DiseaseEfficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe AcneIsotretinoin for Proliferative VitreoretinopathyBiological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory NeuroblastomaAflac ST1001 Prolonged IsotretinoinRA-4: 13-cis Retinoic Acid for Treatment of Men With AzoospermiaComparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk NeuroblastomaDinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell TransplantEfficacy and Safety of Oral Isotretinoin for the Treatment of Facial Recalcitrant Flat WartsIsotretinoin in Treatment of COVID-19Assessment the Activity Value of 13- Cis-Retinoic Acid(Isotretinoin) in the Treatment of COVID-19Treatment With Dinutuximab in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk NeuroblastomaCombination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2Combination Therapy With Isotretinoin and Tamoxifen May Provide Complete Protection Against Severe Acute Respiratory Syndrome CoronavirusCombination With Alvelestat and Isotretinoin May Enhances Neutralizing Antibodies in COVID -19 Infected Patients Better Than COVID-19 Inactivated Vaccines
P4844
Screening of Priority Chemicals for Reproductive Hazards. Triorthocresyl Phosphate (CAS No.: 78-30-8), 4,4'-Thiobis (6-t- Butyl-m-cresol) (CAS No.: 96-69-5), 13-cis-Retinoic Acid (CAS No.: 4759-48-2)Uses and complications of isotretinoin therapy.The use of retinoids in the prevention and treatment of skin cancer.A case of suspected isotretinoin-induced malformation in a baby of a mother who became pregnant one month after discontinuation of the drug.Isotretinoin maintenance therapy for glioblastoma: a retrospective review.Steady-state pharmacokinetics of isotretinoin and its 4-oxo metabolite: implications for fetal safety.Isotretinoin: state of the art treatment for acne vulgaris.Oral side effects of isotretinoin chronic intake.Fetal exposure to isotretinoin-an international problem.Systemic Retinoids and Scar DehiscenceEfficacy of Oral Isotretinoin in Combination with Desloratadine in the Treatment of Common Vulgaris Acne in Vietnamese PatientsUse of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysisDevelopment of Periungual Pyogenic Granuloma with Associated Paronychia Following Isotretinoin Therapy: A Case Report and a Review of the LiteratureThe safety of isotretinoin treatment in patients with bone fracturesEffective Treatment of Morbihan's Disease with Long-term Isotretinoin: A Report of Three CasesPsychiatric and Developmental Effects of Isotretinoin (Retinoid) Treatment for Acne VulgarisFoxO1 enhances differentiation and apoptosis in human primary keratinocytesIdentifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin TreatmentTreatment of acne vulgaris
P921
Q61906776-8C9AB28D-2AE8-4267-90DA-4680F74F3F98Q61922382-211EC0B6-E4EC-4DB1-B4F5-19C11443D176Q61935801-0E500204-36E6-4C4F-9CDB-6F420E7D84D0Q61975464-84DFBF5B-F9F2-4270-A429-0C00C1C900B2Q61980918-B97C2389-3D96-4308-901D-85F8DE123F7CQ62042727-8C703E60-F3AE-4195-82FB-9EF7433C488FQ62105044-694604BF-1A48-4E13-BDCE-5ED5BA932B44Q62110078-E9DF35FC-82A9-4B64-89DD-A29AE5AAF963Q62110260-8D350737-E033-48A8-A67F-2D2E57A620EAQ62110282-D142BEB2-685E-4C7E-87E2-9EA70D014C5DQ62110987-47531E74-859B-4B36-A295-D23DE62B3C72Q62818553-45FE15F8-4993-4CC1-BEC0-4EF891D549C0Q63316644-CDE8680E-77CC-4A25-AB11-EAAEAFF33F05Q63321212-0E134BD9-3AA6-4E32-B12D-77DB3E5FC1CDQ63321720-5994E521-5BF5-4AA6-A786-220D374B8061Q63336462-5E08BC3F-118B-456E-B5CF-4AD811B093FCQ63336808-728CFC10-0365-4674-87E5-FF01AF37A7B0Q63534599-73408F2B-EDF4-481A-9BD6-03E15B6D437DQ63591257-4C88F718-23A6-4B37-A19C-9186139FA30DQ63591834-7CAD310D-4512-4FAF-8BE6-2E1AB2852319Q87078757-551AC6C0-1A66-492B-B221-B54D64C7BFDCQ92273974-A3CDB8E4-29D5-4DA4-9BCC-B8B0DD10C235Q92274051-B1611713-9D18-4C57-BCE6-7976422E2EB4Q94234597-61A95EA2-DB18-43BF-B4A9-0DD76CC0C9A7Q94234947-AA24B4E6-11DD-487E-8E07-9149D6559399Q94573503-C9B167F6-1285-4A4D-8594-5965EAA346D5Q94982275-BAF18A72-1798-4AF8-9478-BE13B07EAE3C
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Isotretinoiin
@et
Isotretinoiini
@fi
Isotretinoin
@de
Isotretinoin
@sv
Isotretinoína
@es
Isotretinoïne
@nl
Izotretinoin
@sh
Izotretinoin
@sl
Izotretinoin
@sr
isotretinoin
@cy
type
label
Isotretinoiin
@et
Isotretinoiini
@fi
Isotretinoin
@de
Isotretinoin
@sv
Isotretinoína
@es
Isotretinoïne
@nl
Izotretinoin
@sh
Izotretinoin
@sl
Izotretinoin
@sr
isotretinoin
@cy
altLabel
(13-cis)-Retinoik asit
@tr
(13-cis)-retinoic acid
@en
(2Z,4E,6E,8E)-3,7-dimethyl-9-( ...... l)nona-2,4,6,8-tetraenoic acid
@en
(7e,9e,11e,13Z)-retinoic acid
@en
13-RA
@en
13-cis-retinoic acid
@en
13-cis-vitamin A acid
@en
Accutane
@et
Accutane
@tr
Amnesteem
@et
prefLabel
Isotretinoiin
@et
Isotretinoiini
@fi
Isotretinoin
@de
Isotretinoin
@sv
Isotretinoína
@es
Isotretinoïne
@nl
Izotretinoin
@sh
Izotretinoin
@sl
Izotretinoin
@sr
isotretinoin
@cy